The RNA silencing endonuclease
Argonaute 2 mediates specific antiviral
immunity Drosophila melanogaster
Ronald P. van Rij,1 Maria-Carla Saleh,1 Bassam Berry,2 Catherine Foo,1 Andrew Houk,1
Christophe Antoniewski,2 Raul Andino1,3
1
 Department Microbiology Immunology, University California San Francisco, San Francisco, California 94143,
USA; 2Department Developmental Biology, Centre national la recherche scientifique (CNRS) URA 2578 Pasteur
Institute, Paris 75015, France



 organisms evolved defense mechanisms protect viruses pathogens.
Arthropods lack protein-based adaptive immune response vertebrates. central catalytic component RNA-induced silencing complex (RISC), nuclease Argonaute 2 (Ago-2), essential antiviral defense adult Drosophila melanogaster. Ago-2-defective flies hypersensitive infection major fruit fly pathogen, Drosophila C virus (DCV), Cricket Paralysis virus (CrPV).
Increased mortality ago-2 mutant flies associated dramatic increase viral RNA accumulation virus titers. physiological significance antiviral mechanism underscored finding DCV encodes potent suppressor RNA interference (RNAi). suppressor binds long double-stranded
RNA (dsRNA) inhibits Dicer-2-mediated processing dsRNA short interfering RNA (siRNA), does bind short siRNAs disrupt microRNA (miRNA) pathway. Based results propose RNAi major antiviral immune defense mechanism Drosophila.
[Keywords: Antiviral defense; RNAi suppressor; dsRNA-binding domain; Drosophila C virus; Cricket Paralysis
virus]
Received August 14, 2006; revised version accepted September 15, 2006.




Higher vertebrates rely highly sophisticated                      plementary sites cytoplasmic RNA (â€œSlicerâ€? activity)
â€œadaptiveâ€? immune targets pathogens                        (Liu et al. 2004). related distinct microRNA
exquisite specificity broad-action, nonspe-                    (miRNA) pathway uses short, endogenously encoded
cific, â€œinnateâ€? immune response includes                        hairpin RNAs sequentially processed ma-
duction nonspecific RNaseL (Silverstein 1989).                    ture miRNAs RNases: nuclear Drosha triguingly, invertebrates lack protein-based adaptive                   cytoplasmic Dicer. miRNAs incorporated
immune response, capable effectively fighting                    miRISC, promotes RNA cleavage transla-
viral infections. raised question                   tional inhibition recognition cognate target sites additional adaptive innate antiviral                       3â¬˜ untranslated region (UTR) mRNAs (Bartel
mechanisms distinct classical mammalian im-                        2004).
mune (Brennan Anderson 2004).                                       miRNAs known regulate gene expression
   RNA interference (RNAi) evolutionarily                         essential proper development cell physiology
served mechanism sequence-specific gene silencing                       (John et al. 2004; Bentwich et al. 2005; Berezikov et al.
guided double-stranded RNA (Meister Tuschl                           2005), function RNAi cleavage pathway 2004). nonspecific endonuclease Dicer cleaves long,                     animals remains unclear. Given RNA silencing
exogenous double-stranded RNA (dsRNA) short                         pathway plays critical role antiviral defense plants
terfering RNA (siRNA), âˆ¼21- 25-base-pair (bp) dsRNA                      (Baulcombe 2004; Voinnet 2005), hypoth- 2-nucleotide (nt) 3â¬˜ overhang. siRNAs                      esized RNAi cleavage pathway animals subsequently incorporated RNA-induced silenc-                        provides defense mechanism parasitic nucleic
ing complex (RISC), guide recognition                        acids, viruses transposons. observa-
Argonaute (Ago)-2-mediated cleavage perfectly com-                       tions support hypothesis. Introduction artificial
                                                                            dsRNA siRNAs insects mammalian cells elic-
3
                                                                            effective antiviral response protects cells
 Corresponding author.
E-MAIL raul.andino@ucsf.edu; FAX (415) 514-4112.                            highly lytic viruses (Gitlin et al. 2002; Li et al.
Article online http://www.genesdev.org/cgi/doi/10.1101/gad.1482006.   2002; van Rij Andino 2006). high specificity 

         GENES & DEVELOPMENT 20:2985â€“2995 Â© 2006 Cold Spring Harbor Laboratory Press ISSN 0890-9369/06; www.genesdev.org         2985
 van Rij et al.



antiviral RNAi highlighted observation          expressing FHV B2 defective RNA silencing elic-
resistant viruses readily emerge single mismatches        ited long dsRNA siRNA, miRNA siRNA-target sequence (Gitlin Andino            pathway (B. Berry C. Antoniewski, unpubl.). B2
2003; Gitlin et al. 2005).  RNA-based antiviral        transgenic flies experienced rapid course dis-
defense mechanism capacity provide highly         ease died faster inoculation DCV. Median
sequence-specific response.  observed sus-         survival 2â€“3 d shorter presence B2 ceptibility viruses synthetic siRNAs does prove      control flies (Fig. 1A). FHV B2 inhibits dsRNA antiviral RNAi response initiated          processing Dicer (Lu et al. 2005; Sullivan Ganem
natural infection.                                             2005), results suggest Drosophila Dicer-2    Recently, evidence surfaced supporting          digest viral dsRNA, consistent recent reports dem-
cept RNAi involved defense viruses      onstrating increase viral replication Dicer-2-null insects (Keene et al. 2004; Sanchez-Vargas et al. 2004;     mutant flies (Galiana-Arnoux et al. 2006; Wang et al.
van Rij Andino 2006). Components RNAi ma-           2006). Digestion viral dsRNA  principle, ac-
chinery, including Dicer-2 cofactor R2D2,         count antiviral activity Dicer. Alternatively,
shown required defense fruit flies        Dicer initiate sequence-specific antiviral
viral infection (Galiana-Arnoux et al. 2006; Wang et al.       response, viral siRNAs generated Dicer-2 2006). Dicer sequence-nonspecific endo-           incorporated RISC, used target single-
nuclease, principle possible antiviral       stranded viral RNA destruction. case,
function RNAi pathway elements relies cleav-         hypothesized antiviral activity flies age essential double-stranded intermediates RNA          impaired loss RISC function.
replication Dicer, similar innate response car-
ried RNaseL mammals. Alternatively, 
tiviral activity rely sequence-specific activi-
ties RNAi response. scenario, viral siRNAs
produced Dicer-2 incorporated RISC, leading specific cleavage viral mRNAs RISC 
consequently, suppression virus infection.
   distinguish possibilities, test RNAi plays central auxiliary role antiviral defense, investigate role RISC response viral infection Drosophila melanogas-
ter. flies defective catalytic com-
ponent RISC, nuclease Ago-2, hypersensitive infection Drosophila C virus (DCV) Cricket
Paralysis virus (CrPV), resulting 1000-fold increase virus production.  Ago-2/Slicer key 
tiviral response adult fruit flies. Furthermore, iden-
tified suppressor RNAi encoded DCV genome,
supporting central role RNAi natural antiviral
defense flies. suppressor specifically binds long
dsRNA, inhibits Dicer processing, inhibits
dsRNA-initiated RNAi.  results provide
direct support notion RNAi central natural antiviral immune response Drosophila.


Results
                                                               Figure 1. D. melanogaster RNAi mutant flies hypersensi- RISC catalytic component Ago2 required                  tive virus infection.   Transgenic expression flock
                                                               house virus B2 protein, inhibitor Dicer function, increases protection virus infection
                                                               sensitivity DCV infection. Flies indicated genotypes examine mechanism antiviral immunity          injected abdomen 350 TCID50 DCV, sur-
fruit fly employed Drosophila C virus (DCV), posi-        vival monitored daily. B2 expression  control tive-strand RNA virus bicistrovirus family        UASp sequence) induced crossing UAS-B2 flies flies major pathogen Drosophila. Injection DCV        expressing Gal4 transcription factor Daughterless
                                                               promoter. F1 progeny cross (B2/+; Gal4/+, open
abdomen fly results dose-dependent mortality
                                                               squares) expressed B2, B2 expression detectable
(Cherry Perrimon 2004). evaluate importance         control crosses (data shown). (B,C) Survival Ago- insect RNAi machinery controlling virus repli-       2-null male female mutant flies virus infection. Ho-
cation, initially studied effect potent viral      mozygous ago-2âˆ’/âˆ’, dcr-2âˆ’/âˆ’, wild-type (wt) flies 
suppressor RNAi, flock house virus B2 protein (Lu       jected 350 TCID50 DCV (B) CrPV (C) monitored
et al. 2005; Sullivan Ganem 2005). Transgenic flies        daily survival.


2986        GENES & DEVELOPMENT
                                                                                                                   Antiviral function Ago2



   directly establish antiviral response flies mediated RISC examined function catalytic component RISC, Ago2, protection virus infection. ago2414 mutant flies (ago2âˆ’/âˆ’)
carry partial deletion ago-2 gene, conse-
quently produce Ago2 defective RNAi
(Okamura et al. 2004). Strikingly, ago-2âˆ’/âˆ’ Dicer-2âˆ’/âˆ’
mutant flies hypersensitive virus infection related bicistroviruses, DCV CrPV. Ago2-defective flies, observed earlier onset disease wild-type flies (Fig. 1B,C; Table 1). injection 350 TCID50 virus, median survival ago2âˆ’/âˆ’ flies âˆ¼5 d viruses, compared >14 d wild-type flies. Furthermore, disease occurred lower viral doses. 50  lethal dose (LD50) ago-2âˆ’/âˆ’ B2 transgenic flies 40- 280-fold lower control flies (Table 1). experiments indi-
cate RISC activity plays central role effective
antiviral defense adult flies.


Increased susceptibility virus infection ago-2âˆ’/âˆ’
mutant flies associated increased levels viral RNA accumulation virus titers important caveat studying viral sensi-
tivity flies defective components major
cellular pathway, RNAi. Enhanced death follow-
                                                                         Figure 2. DCV replicates higher levels ago-2-null mutant
ing viral infection caused decrease fitness
                                                                         flies.   Homozygous ago-2âˆ’/âˆ’ wild-type flies injected general health mutant animal,                                                                          350 TCID50 DCV, virus production flies direct antiviral activity deleted component. Ac-                  monitored time. time point, pools flies
cordingly, tested increased mortality                  homogenized, viral titer homogenate ago-2âˆ’/âˆ’ mutant flies associated direct                    determined end-point dilution. Titers represent averages crease virus replication (Fig. 2). early time                 standard deviations independent pools flies 
points post-infection, viral titers 1000-fold higher                (B,C) DCV RNA accumulation efficient ago-2âˆ’/âˆ’-null ago-2âˆ’/âˆ’ flies compared wild-type controls (Fig.                 mutant flies. ago-2âˆ’/âˆ’ wild-type flies injected 350
2A), indicating Ago2 plays direct role sup-                TCID50 DCV, 25 flies harvested daily detection pressing viral replication. viral titers wild-type                viral RNA. (B) Ethidium bromide-stained agarose gel total
                                                                         RNA preparation. (C) Northern blot analysis viral RNA. controls follow increased                                                                          loading control, blots stripped rehybridized âˆ¼5 log10 TCID50 fly  days 5, 8, 11 post-infec-
                                                                         probe specific actin 42A. Numbers panels
tion), reached virus production levels                indicate days post-infection.
observed ago-2âˆ’/âˆ’ flies days 2 3 post-infection

                                                                         (âˆ¼8.0 log10 TCID50). increase viral titers ago-
Table 1. Lethal viral doses RNAi-defective flies                      2âˆ’/âˆ’ flies mirrored dramatic increase viral
Drosophila strain                 Virus                LD50(TCID       RNA levels (Fig. 2B,C).  viral RNA Ago-2âˆ’/âˆ’
                                                                         mutant flies infected DCV 2 3 d Wild-type                         DCV                       171          directly detected following ethidium bromide staining agoâˆ’/âˆ’                                                        4
                                                                         agarose gel analyzing total RNA. contrast, wild-
+/+; Gal4/+                       DCV                       118
B2/+; +/+                                                    70
                                                                         type control flies viral RNA undetectable 9
B2/+; Gal4/+                                                <21b         d post-infection (Fig. 2B). confirmed iden-
Wild-type                         CrPV                     1359          tity RNA bands observed ethidium bro-
agoâˆ’/âˆ’                                                        5          mide-stained gel Northern blot analysis (Fig. 2C).
                                                                         wild-type flies viral RNA barely detected
Calculation LD50 values mutant strain using                                                                          day 6, ago-2âˆ’/âˆ’ mutant flies virus RNA Reed Muench method.   LD50 values expressed TCID (tissue culture infectious
                                                                         clearly observed 24 h post-infection, 48 h virus
doses).                                                                  RNA accumulated higher levels wild-
b
  B2/+; Gal4/+ cross, >50  flies died highest di-   type control flies (Fig. 2C). conclude 
lution tested, LD50 value established.     hanced viral susceptibility ago-2âˆ’/âˆ’ flies number represents upper limit actual LD50 value.          inability control virus replication. dramatic 


                                                                                                      GENES & DEVELOPMENT              2987
 van Rij et al.



crease viral titers observed RISC inactivated
establishes ago-2 host susceptibility locus virus
infection provides direct rationale acceler-
ated progression disease ago-2âˆ’/âˆ’ flies.


DCV encodes potent suppressor RNAi pathway results indicate RNAi pathway central highly potent antiviral defense mechanism flies.
Given plant viruses partially overcome antiviral RNAi response encoding suppressors RNA silencing, hypothesized DCV, 
der stringent RNAi control flies, evolved
similar RNAi suppressive activities. determine DCV encodes suppressor RNAi, Drosophila
S2 cells infected DCV  24 h later, cotransfected reporter RNAi silencing
activity, consisting Renilla luciferase-expressing
plasmid specific 541-nt-long dsRNA targeting 
nilla mRNA. transfection control consisting unrelated firefly luciferase included experi-
                                                             Figure 3. Drosophila C virus encodes suppressor long
ment. uninfected control cells, Renilla expression    dsRNA-initiated RNAi.   Uninfected DCV-infected Dro-
efficiently silenced (798-fold suppression compared     sophila S2 cells transfected expression plasmids  control dsRNA). contrast, silencing ineffi-    coding firefly Renilla luciferase 541-bp dsRNA
cient DCV-infected cells (sixfold suppression) (Fig.      targeting Renilla luciferase unrelated control dsRNA. Renilla
3A).  DCV infection inhibits RNAi            luciferase counts normalized using firefly luciferase
duced 541-nt-long dsRNA. examined         counts, data expressed fold silencing compared mechanism viral inhibition RNAi silencing.          control dsRNA. (B) Experiment performed described cause long dsRNA needs processed siRNA          21-bp synthetic siRNA targeting firefly luciferase 
                                                             related control siRNA cotransfected initiate RNAi. (C)
Dicer-2 order induce gene silencing, deter-
                                                             Experiment performed described  RNAi initi-
mined DCV inhibits RNAi disrupting
                                                             ated dsRNAs 21â€“592 nt length, indicated. Silencing
dsRNA processing. end, repeated experi-       expressed percent silencing DCV-infected unin-
ment using synthetic 21-bp siRNA silence firefly lu-      fected S2 cells. Data Aâ€“C indicate averages standard 
ciferase expression short RNAs directly      viations independent experiments. (D) Processing corporated RISC, overcoming need           dsRNA Drosophila S2 cell extract. S2 cells mock-infected,
Dicer processing. case, siRNA-induced silencing      infected DCV CrPV 20 h preparation cell affected DCV infection (Fig. 3B).      extracts, MOI 1. Processing 116-bp dsRNA 21-bp
define substrate DCV RNAi suppressor,          siRNA analyzed 12  denaturing polyacrylamide gel. used panel dsRNA preparations different sizes     end-labeled 21-bp synthetic siRNA used size marker.
induce RNAi firefly luciferase reporter (Fig. 3C).
DCV suppressed RNAi induced dsRNA ranging            involved processing long dsRNA RNAi
31 bp 592 bp length, unable inhibit      pathway (Lee et al. 2004), Dicer-1, involved 21-bp siRNA-initiated RNAi; furthermore, suppression         miRNA biogenesis. determine suppres- RNAi efficient longer dsRNA prepara-        sor activity encoded DCV general inhibitor tions (Fig. 3C). data suggest DCV        Dicer-like activities, examined DCV
suppressor RNAi acts upstream RISC,         disrupts miRNA pathway. end, moni- level dsRNA processing Dicer-2, pro-         tored miRNA levels infected S2 cells time vides siRNAs RNAi silencing pathway.          Northern blotting (Fig. 4A). levels mature
directly test possibility, studied virus     miRNA ratio pre-miRNA mature miRNA
infection inhibits Dicer-2 activity cell extracts.      processing step mediated Dicer-1) prepared S2 cell extracts uninfected cells      changed infected cells. examined cells infected DCV CrPV 20 h prior      endogenous miRNAs assemble functional
preparation extracts. uninfected extracts dsRNA        RISC DCV-infected cells. used firefly luciferase efficiently processed 21-bp siRNAs (Fig. 3D, lane     reporter coding mRNA containing copies 2). contrast, siRNA production inhibited DCV-      sequence targeted mature miR2b 3â¬˜UTR
infected extracts (Fig. 3D, lane 3). Inhibition Dicer-2   (Fig. 4B, antisense; Saleh et al. 2006). control, function specific DCV, closely related     used firefly luciferase mRNA containing se-
CrPV did affect dsRNA processing (Fig. 3D, lane 4).      quences reverse orientation (Fig. 4B, sense). S2
   Drosophila encodes Dicer-related genes: Dicer-2,      cells cotransfected firefly luciferase


2988        GENES & DEVELOPMENT
                                                                                                             Antiviral function Ago2



                                                                       identified canonical dsRNA-binding domain (dsRBD)
                                                                       N terminus ORF-1 DCV. hypothesized
                                                                       domain responsible suppression                                                                        RNAi, given plant virus suppressors RNAi
                                                                       bind dsRNA (Lakatos et al. 2006; Merai et al. 2006)                                                                        observation dsRNA processing inhibited                                                                        DCV infection. subcloned dsRBD varying
                                                                       lengths flanking sequence tested ability sup-
                                                                       press RNAi Drosophila S2 cells (Fig. 5A).                                                                        dsRBD likely N-terminal functional viral
                                                                       gene product, tentatively refer protein                                                                        DCV-1A.
                                                                          Expression small fragment 99 residues,
                                                                       include N-terminal 22 amino acids ORF-1,
                                                                       66-amino-acid minimal dsRBD, 11 amino acids
                                                                       C-terminal sequence, able efficiently suppress
                                                                       RNAi (Fig. 5B). Increasing length DCV frag-
                                                                       ment did augment efficiency suppres-
                                                                       sion RNAi. dsRBDs highly conserved                                                                        studied protein domains (Tian et al. 2004; Chang                                                                        Ramos 2005). determine DCV-1A suppres-
                                                                       sion requires binding dsRNA, mutated highly 
                                                                       served residues dsRBD (L28Y AA80KK)                                                                        residues expected interact dsRNA based avail-
                                                                       able structures (E51A KK73AA) (Fig. 5C).                                                                        mutations abolished RNAi suppression, includ-
                                                                       ing KK73AA substitution expected directly inter-
                                                                       act dsRNA (Fig. 5D).
Figure 4. DCV infection does affect miRNA biogenesis              test DCV-1A inhibit RNA silencing function.   Processed miRNA levels DCV-infected            intact animal, generated transgenic flies express-
infected S2 cells. S2 cells infected DCV MOI        ing WT-DCV-1A, inactive KK73AA mutant, GFP
0.01 100, presence miR2b time analyzed         control developing eye. Efficiency RNA Northern blot. loading control, blot stripped      silencing monitored flies crossing rehybridized probe specific U6 snRNA. (B) miR2b          flies expression mini-white genes assembled functional RISC complexes. Uninfected                                                                        suppressed expression hairpin dsRNA targeting
DCV-infected (MOI 1) S2 cells transfected plas-
mid expressing luciferase mRNA containing copies                                                                        white gene. conditions white gene
sequence perfectly complementary mature miR2b            efficiently silenced, evidenced loss red eye sense antisense orientation 3â¬˜UTR. Lucifer-       pigmentation resulting orange eye color GFP
ase activity normalized expression cotransfected       control flies (Fig. 5E, GFP). flies expressing wild-
Renilla luciferase plasmid does contains miR2b comple-        type DCV-1A, RNA silencing efficiently suppressed,
mentary sites. Luciferase activity expressed ratio    resulting expression white gene  accord-
malized luciferase counts luciferase-miR-2 antisense lucif-    ingly, red eye color. expected, flies expressing erase-miR-2 sense transfections. Bars indicate averages stan-      KK73AA DCV-1A mutant, unable suppress
dard deviations independent experiments.                       RNAi cell culture (Fig. 5D), white gene si-
                                                                       lenced, albeit efficiently GFP-transgenic
miR2b reporters Renilla luciferase                   control flies (Fig. 5E). Taken  data indicate
transfection control. hours transfec-                DCV-1A protein acts potent RNAi suppres-
tion, luciferase expression induced luciferase                 sor flies confirm dsRBD crucial activity monitored. ratio firefly lucif-               suppressor activity.
erase activity mRNA containing sense antisense
miR2b sequence virtually identical infected                                                                        DCV-1A binds long dsRNA high affinity uninfected S2 cells (Fig. 4B).  DCV encodes ac-
                                                                       inhibits Dicer processing
tivity specifically inhibits RNAi silencing initiated long dsRNAs does affect miRNA pathway.                     examine DCV-1A suppressor activ-
                                                                       ity mediated direct binding dsRNA Dicer-2
                                                                       substrate, expressed DCV-1A fusion glutathi- RNAi suppressor dsRNA-binding protein
                                                                       transferase (WT-DCV-1A) Escherichia coli encoded N terminus ORF-1
                                                                       analyzed dsRNA binding electrophoretic mobility define viral factor responsible RNAi suppres-               shift assays (EMSA). control, analyzed inac-
sion, examined amino acid sequence DCV                   tive mutant suppressor, L28Y-DCV-1A (Fig. 3C). 

                                                                                                  GENES & DEVELOPMENT            2989
 van Rij et al.




Figure 5. Drosophila C virus dsRBD pro-
tein suppressor RNAi.   Sche-
matic representation DCV genome. graphic indicates dsRBD 
taining domains cloned ex-
amined suppression RNAi. (B) Dro-
sophila S2 cells transfected plasmids expressing firefly Renilla lu-
ciferase indicated dsRBD-contain-
ing DCV ORF-1 domains. RNAi initi-
ated adding dsRNA specific firefly
luciferase control dsRNA culture
supernatant. Data expressed fold si-
lencing compared control unrelated
dsRNA. Note soaking dsRNA efficient method induce silencing cotransfecting dsRNA, Fig-
ure 3. (C) Alignment dsRBD sequences DCV different model organisms.
Boxed residues indicate residues di-
rectly interact dsRNA Xenopus
laevis RNA-binding protein X-ray
structure (Ryter Schultz 1998). (D)
Suppression RNAi wild-type mutant DCV dsRBD S2 cells. Experi-
ment performed described B.
Data B D indicate averages standard deviations independent
experiments. (E) DCV-1A suppresses
RNAi vivo. RNA silencing white
gene inverted repeat  [W]) flies transgenic wild-type (wt) KK73AA DCV-1A, GFP control.
Maximum white gene expression absence RNAi examined GMR-Gal4/+; UASp-GFP/+ control flies express inverted repeat (left
panel, control).


WT-DCV-1A associated 211-bp-long dsRNA              affinity diverse set dsRNAs, indicating probe high affinity (Fig. 6A,B), L28Y-DCV-1A      interaction sequence nonspecific (data shown). mutant unable interact dsRNA (Fig. 6C,     tissue culture, DCV infection inhibited RNAi function
lanes 4â€“10). increasing concentrations WT-DCV-     elicited exogenous dsRNA 31 bp longer,
1A, discrete bands appeared decreasing mobility,      DCV unable prevent siRNA-initiated si-
indicating multiple binding events DCV-1A single   lencing (Fig. 3B). Furthermore, suppression RNAi dsRNA. observed binding ssRNA DCV-1A           efficient longer, 116- 592-bp, dsRNA prepa-
(Fig. 6C, lanes 11â€“18), DCV-1A bound similar      rations (Fig. 3C). examined binding


2990        GENES & DEVELOPMENT
                                                                                                                      Antiviral function Ago2




Figure 6. DCV-1A dsRNA-binding activity inhibits Dicer processing dsRNA.   RNA mobility shift analyses showing
binding DCV-1A dsRNA 211 bp (left panel) 31 bp (middle panel), 21-bp siRNA (right panel). probe incubated buffer (âˆ’) increasing concentrations WT-DCV-1A. Concentrations protein 0 (lanes 1,9,15), 0.0001 (lanes
2,16), 0.001 (lanes 3,10,17), 0.005 (lanes 4,11,18), 0.01 (lanes 5,12,19), 0.05 (lanes 6,13,20), 0.1 (lanes 7,14,21), 0.5 ÂµM (lane 8).
Position free probe indicated arrows. (B) Binding affinity WT-DCV-1A dsRNAs indicated lengths. percentage radiolabeled probe bound DCV-1A total probe mobility shift assays plotted WT-DCV-1A concentrations. (C)
RNA mobility shift assay mutant L28Y-DCV-1A 211-bp dsRNA (left panel) WT-DCV-1A 211-nt ssRNA (right panel). probe incubated buffer (âˆ’) increasing concentrations wild-type mutant DCV-1A. mobility shift assay WT-DCV-1A 211-bp dsRNA probe run parallel positive control (lanes 1,2). Concentrations protein 0 (lanes
1,3,11), 0.0001 (lanes 4,12), 0.001 (lanes 5,13), 0.005 (lanes 6,14), 0.01 (lanes 7,15), 0.05 (lanes 8,16), 0.1 (lanes 9,17), 0.5 ÂµM (lanes
2,10,18). (D) DCV-1A inhibits Dicer processing S2 cell extracts. Radiolabeled 116-bp dsRNA processed siRNA S2 cell
extract presence increasing concentrations wild-type L28Y-DCV-1A buffer (âˆ’). Reaction products analyzed 12  denaturing polyacrylamide gel. end-labeled 21-bp synthetic siRNA used size marker (Mkr). Concentrations DCV-1A protein 0 (lane 2), 0.5 (lane 3), 0.125 (lanes 4,8), 0.05 (lanes 5,9), 0.005 (lanes 6,10), 0.00125 ÂµM (lanes 7,11).


 DCV-1A depends size dsRNA. WT-DCV-                       Dicer-2 (Fig. 6D, lane 2). Addition wild-type DCV-1A
1A does bind efficiently 21-bp siRNA,                   inhibited Dicer activity dose-dependent manner (Fig.
formed weak complexes highest protein concen-                      6D, lanes 3â€“7). contrast, L28Y DCV-1A mutant
tration used (Fig. 6A [lanes 15â€“21], B). contrast,                  effect Dicer activity (Fig. 6D, lanes 8â€“11).
observed increasing binding affinity DCV-1A                        results indicate DCV-encoded RNAi sup-
dsRNA probes increasing size (Fig. 6A,B).                     pressor requires dsRNA-binding activity inhibition affinity DCV-1A different lengths dsRNA                     Dicer-2 function. Furthermore, biochemical analy-
closely correlates efficiency DCV mediate sup-                 ses, indicated binding short dsRNAs pression RNAi (Fig. 3C).                                               suppressor inefficient, explain observations
   establish DCV-1A directly respon-                       DCV unable inhibit siRNA- miRNA-initi-
sible observed inhibition Dicer activity (Fig.                 ated RNAi vivo.
3D), analyzed processing dsRNA siRNA cell extracts presence recombinant DCV-1A. S2
                                                                          Discussion
cell extracts incubated dsRNA presence increasing concentrations wild-type mutant                       results support notion RNA silencing DCV-1A. absence exogenous viral protein,                        crucial antiviral defense adult D. melanogaster.
dsRNA efficiently processed 21-bp siRNA                        severity infection observed flies lacking func-


                                                                                                         GENES & DEVELOPMENT              2991
 van Rij et al.



tional RISC, infectious viral particles suf-       trigger dsRNA imply natural viral sub-
fice rapidly kill adult animal (Fig. 1; Table 1), argue   strate Dicer-2 consists dsRNA replication central role RNAi antiviral response.         intermediate stem loops longer 30 nt. Additional
antiviral mechanism depends combined action            insight comes study small RNA profile
Dicer-2 Ago-2. Dicer-2 senses cleaves dsRNA,             developing flies (Aravin et al. 2003). Dro- generating siRNA recognition signal guides          sophila stocks used study persistently 
RISC cleavage viral RNA Ago-2. turn, DCV            fected DCV, 17 small RNAs derived encodes counterdefense mechanism consists            DCV cloned. Based size profile pre-
canonical dsRBD suppresses RNA silencing initi-             dominant detection small RNAs genomic
ated long dsRNA, inhibition Dicer activity.          viral RNA, authors argued small RNAs
cause siRNAs sequence-specific guides cleavage,          true Dicer cleavage products (Aravin et al. antiviral mechanism represent inverte-            2003). detailed systemic analysis siRNAs
brate homolog sequence-specific â€œadaptiveâ€? im-              DCV infection needed clearly define mune response, respond ongoing            Dicer-2 substrate virus-infected flies.
infection pathogen-specific manner. remains           important question determine tested specific signals persist organism          viruses escape inhibitory effect RNAi. mecha- prolonged periods time, providing akin          nism, identified study, relies suppressor â€œimmunological memory,â€?                 dsRNA-binding activity inhibits Dicer processing mechanisms spread â€œimmuneâ€? antiviral activ-           dsRNA. mechanism observed RNA
ity organism.                                     silencing suppressors plant viruses (Vargason et al.
   RNA silencing instrumental local sys-          2003; Ye et al. 2003; Lakatos et al. 2006; Merai et al.
temic antiviral response plants. RNAi pathway             2006), B2 protein insect virus Flock diversified extensively evolution plants.          house virus (Chao et al. 2005; Lingel et al. 2005; Lu et al. example, Arabidopsis encodes Dicer-like genes           2005; Sullivan Ganem 2005). note, DCV does 10 Argonaute genes. diversification allow           provide general inhibition Dicer-2 Ar-
plants efficiently process different dsRNA substrates,        gonaute-2 activity, displays substrate-specific silence gene expression different effector mecha-        inhibition RNAi. RNAi initiated long
nisms (Baulcombe 2004; Xie et al. 2004).            dsRNA inhibited, short siRNA-mediated RNAi differential requirement Dicer-like        affected. evolutionary perspective, viruses adapt
genes, DCL2 DCL4, local antiviral silencing          level pathogenicity hosts ensure spread silencing signal, respectively (Deleris et al.     transmit viral progeny. presence 2006).  effector mechanism antiviral             RNAi suppressor allow virus fine-tune RNA silencing plants remains undefined. 10             severity infection,  example, cru-
Argonaute family members Arabidopsis, Argo-              cial establish persistent infection natural infec-
naute 1 far demonstrated contain Slicer         tions.
activity, does appear associate viral            conclude inhibition RNAi dsRNA bind-
siRNA (Baumberger Baulcombe 2005).              ing extends realm plant viruses, stage unclear antiviral defense           occurs insect viruses. note, CrPV, closely
plants dependent Slicer-dependent RNAi cleavage          related DCV, encodes RNAi suppressor maps
activity.                                                        genomic region DCV (Wang et al. 2006).
   Drosophila encodes Dicer genes Argo-               DCV depends canonical dsRBD
naute genes, dedicated miRNA pathway               RNAi suppression, domain pre-
(Dicer-1 Ago-1) RNAi cleavage pathway                 dicted CrPV  members bicistrovirus
(Dicer-2 Ago-2) (Lee et al. 2004; Okamura et al.             family) (R. van Rij R. Andino, unpubl.). agreement
2004). study, recent reports (Galiana-          CrPV did inhibit dsRNA processing S2
Arnoux et al. 2006; Wang et al. 2006), establish        cells, suggesting different mechanism action antiviral function RNAi conserved evolu-           CrPV RNAi suppressor. suggests independent, 
tion, antiviral immunity Drosophila            vergent evolution RNAi suppressor function pendent Slicer/Ago-2-mediated effector mechanism.           closely related viruses. reduced genetic complexity makes Drosophila attractive model study antiviral func-
tion RNAi, questions remain. instance,         Materials methods
unclear types RNA structures recognized Dicer-2 initial cleavage          Cells, plasmids, viruses
mechanism feature allowing RNAi machinery                                                                  Drosophila S2 cells (Invitrogen) cultured 25Â°C selectively target viral species endogenous              Schneiderâ€™s Drosophila medium (GIBCO), supplemented dsRNA. number observations provide insights            10  heat-inactivated fetal calf serum, 2 mM L-glutamine, 100 physiological substrates Dicer-2             U/mL penicillin, 100 mg/mL streptomycin. Firefly (Photi- observation suppression RNAi mediated             nus pyralis) Renilla reniformis luciferase sequences DCV increased efficiency increasing length            plasmids pGL3 pRL-CMV (Promega) cloned 

2992        GENES & DEVELOPMENT
                                                                                                                Antiviral function Ago2


pMT/V5-HisB (Invitrogen), generating pMT-Luc pMT-Ren,            Fly infections vivo RNAi
allowing copper-inducible expression metallothein pro-
                                                                     Flies reared standard medium 25Â°C. Ago-2414 moter. cDNA fragments spanning DCV dsRBD cloned
                                                                     Dcr-2L811fsX flies described previously (Lee et al. 2004; control Actin promoter pAc5/V5-HisB. Mu-
                                                                     Okamura et al. 2004); w1118 flies used wild-type 
tations constructs introduced using Quick-
                                                                     trols. UAS-B2 flies described (B.
Change site-directed mutagenesis kit (Stratagene). sensor
                                                                     Berry C. Antoniewski, prep.). Briefly, FHV B2 ORF miRNA biogenesis function, copies sequence
                                                                     wild-type KK73AA mutant DCV-1A PCR-amplified perfectly complementary mature miR2b                                                                      cloned pENTR-D-TOPO vector using pENTR
sense antisense orientation cloned 3â¬˜UTR                                                                      directional TOPO Cloning Kits (Invitrogen), subsequently
luciferase gene pMT-Luc, described (Saleh et al. 2006).
                                                                     transferred pUASP vector (Rorth 1998) adapted    Transfections performed using Effectene transfection 
                                                                     Gateway (details provided request). Transgenic
agent (Qiagen) according manufacturerâ€™s recommenda-
                                                                     stocks established using standard injection procedure. B2
tions. Luciferase expression assayed using Dual-Lucif-
                                                                     expression induced crossing UAS-B2 flies Daugh-
erase Reporter Assay (Promega) analyzed Tecan
                                                                     terless Gal4 flies, F1 progeny challenged Ultra-evolution plate reader. DsRNA generated vitro
                                                                     DCV.  day-old female flies injected 50
transcription T7-promoter-flanked PCR products. Syn-
                                                                     nL appropriate virus dilution 10 mM Tris-Cl (pH 7.5) thetic siRNAs purchased Dharmacon.
                                                                     described previously (Cherry Perrimon 2004), using    DCV dsRBD (DCV position 1â€“99) cloned                                                                      Drummond nanoject injector. Fly mortality day 1 attrib-
pGex4T.1 (GE Healthcare) expression glutathione S-
                                                                     uted damage invoked injection procedure, transferase fusion protein E. coli BL21(DE3) strain.                                                                      flies excluded analyses. Mortality moni-
fusion protein purified using glutathione agarose resin
                                                                     tored daily 14 d, 3â€“4 d flies transferred (GST-bind, Novagen) according recommendations                                                                      fresh food. experiments, 40â€“60 flies genotypic group
manufacturer, dialyzed overnight 20 mM Tris-HCl,
                                                                     injected. Unless noted  female flies used.
0.5 mM EDTA, 5 mM MgCl2, 1 mM DTT, 140 mM NaCl, 2.7
                                                                     significant difference survival observed mM KCl, 30  glycerol (pH 7.9).
                                                                     Ago-2 wild-type flies injection buffer (data    DCV CrPV stocks prepared low-passage S2 cells
                                                                     shown). Northern blots, RNA isolated 25 flies titered end-point dilution. Briefly, 25,000 S2 cells                                                                      using Trizol reagent. Viral titers flies determined 96 plate inoculated 10-fold dilutions                                                                      end-point dilution fly homogenate pools flies.
viral stocks. Cells transferred fresh medium day 7,
                                                                     indicated time points, flies harvested stored CPE monitored visually 14 d. Viral titers                                                                      âˆ’70Â°C processing. confirmed absence calculated according method Reed Muench (1938).
                                                                     endogenous virus fly stocks titration uninfected fly
                                                                     homogenate S2 cells (data shown). vivo RNAi
                                                                     experiments, established UAS-WT DCV-1A UAS-
RNAi S2 cells
                                                                     KK73AA DCV-1A transgenic lines DCV suppres- ability DCV suppress RNAi analyzed silencing        sor variant form expressed control luciferase expression presence absence virus infec-     GAL4-inducible UAS promoter (Rorth 1998). P{GMR-wIR}
tion. hours prior transfection, S2 cells      transgenic stock (Lee et al. 2004) recombined genetic
fected DCV multiplicity infection (MOI) 1.     crosses w1118, P{w+, GMR-GAL4} line obtain cells cotransfected pMT-GL3 pMT-Ren,          w1118, P{GMR-wIR}; P{w+,GMR-GAL4} homozygous RNAi sen- dsRNA targeting Renilla luciferase synthetic            sor line. Homozygous P{w+, pUAS-Wt-DCV}, P{w+, pUAS-
siRNA targeting firefly luciferase. hours          KK73AA-DCV}, P{w+, pUAS-GFP} crossed sensor
transfection, expression luciferase induced adding         line, adult progeny scored 2 d hatching.
CuSO4 culture supernatant, cell lysates gener-
ated additional 18 h incubation. MiRNA function         Gel mobility shift assays
tested cotransfection S2 cells pMT-Ren        Uniformly labeled 116- 211-bp dsRNA probes gener- miRNA sensor pMT-Gl3-miR2b sense antisense.               ated vitro transcription sense antisense sequence experiment performed described  abil-       presence â?£-32P-UTP T7 RNA polymerase. probes
ity DCV dsRBD suppress RNAi analyzed             purified 6  denaturing acrylamide gel, dis-
transfection pAc-dsRBD pMT-luc pMT-Ren. day           solved annealed HMK buffer (200 mM Hepes pH 7.9,
2, RNAi induced adding dsRNA targeting firefly lucif-         600 mM KCl, 100 mM MgCl2). Synthetic 21-bp siRNA 31-,
erase culture supernatant. Luciferase expression       40-, 51-, 116-bp dsRNA, end-labeled â?¥-32P using
duced 24 h feeding dsRNA, cell lysates pre-        polynucleotide kinase purified G25 microspin column
pared additional 18 h incubation.                           (GE Healthcare). Probe (1.5 nM) incubated varying
                                                                     protein concentrations presence 31.25 mM DTT, 0.625
                                                                     mg/mL yeast tRNA binding buffer (5 mM Hepes pH 8.0, 25
Northern blots                                                       mM KCl, 2 mM MgCl2, 3.8  glycerol) 30 min room
MiRNAs detected using Northern blot previously            temperature. Gel shifts 21-bp siRNA 31- 116-bp
scribed (Aravin et al. 2003). blot hybridized 32P-      dsRNA assayed 8  native polyacrylamide gels; gel
labeled oligonucleotide antisense mature miR-2b. control       shifts 200-bp dsRNA assayed 6  native gels. Gels equal loading, blot stripped hybridized probe   run 4Â°C. Radioactivity mobility shifts quantified
complementary U6 snRNA (5â¬˜-TGGAACGCTTCAC                          Typhoon 9400 Imager (Amersham Biosciences).
GATTTTG-3â¬˜). Viral RNA detected Northern blot using
                                                                     Analysis Dicer activity
standard procedures random primed DNA probe corre-
sponding nucleotides 1947â€“2528 DCV (accession  NP           Dicer activity determined cell extracts uninfected
044945).                                                             DCV- CrPV-infected S2 cells. Cells infected 20 h


                                                                                                   GENES & DEVELOPMENT              2993
 van Rij et al.

 preparation cell extracts, MOI 1. Cells           pathogenesis. Nat. Immunol. 5: 81â€“87.
washed PBS, resuspended lysis buffer (15 mM Hepes/            Deleris, , Gallego-Bartolome, J., Bao, J., Kasschau, K.D., Car-
KOH pH 7.4, 50 mM KOAc, 1 mM Mg[OAc]2, protease                     rington, J.C., Voinnet, O. 2006. Hierarchical action hibitors), frozen âˆ’80Â°C. Prior use, extracts               inhibition plant Dicer-like proteins antiviral defense.
thawed ice centrifuged 14,000g 20 min.               Science 313: 68â€“71.
sulting supernatant tested Dicer activity 3 h 25Â°C,    Galiana-Arnoux, D., Dostert, C., Schneemann, , Hoffmann, previously described (Haley et al. 2003), using gel-purified           J , Imler, J.L. 2006. Essential function vivo uniformly labeled 116-bp dsRNA. reaction products                Dicer-2 host defense RNA viruses Drosophila.
deproteinized proteinase K phenol extraction ana-              Nat. Immunol. 7: 590â€“597.
lyzed 12  denaturing polyacrylamide gel.                         Gitlin, L. Andino, R. 2003. Nucleic acid-based immune
                                                                           antiviral potential mammalian RNA silenc-
                                                                          ing. J. Virol. 77: 7159â€“7165.
                                                                      Gitlin, L., Karelsky, S., Andino, R. 2002. Short interfering
Acknowledgments
                                                                          RNA confers intracellular antiviral immunity human thank members Andino Pat Oâ€™Farrell laboratory               cells. Nature 418: 430â€“434. discussions, technical support, advice fly work.        Gitlin, L., Stone, J.K., Andino, R. 2005. Poliovirus escape
thank O. Voinnet J.L. Imler helpful discussions.               RNAi: siRNA-target recognition implications thank Judith Frydman Annemieke Jansens critical read-             therapeutic approaches. J. Virol. 79: 1027â€“1035.
ing manuscript. Peter Sarnow Sarah Cherry kindly pro-         Haley, B., Tang, G., Zamore, P.D. 2003. vitro analysis vided DCV CrPV virus stocks. grateful C. Vaury              RNA interference Drosophila melanogaster. Methods 30: gift B2 DNA, D. Fagegaltier, L. RÃ¶der, E.           330â€“336.
Georgenthum, BestGene, , generating transgenic        John, B., Enright, J., Aravin, , Tuschl, T., Sander, C., flies. Armin Hekele prepared dsRNA used               Marks, D.S. 2004. Human MicroRNA targets. PLoS Biol. 2:
study. thank Richard Carthew providing GMR-wIR                 e363.
fly stock, Phil Zamore providing fly RNAi mutants         Keene, K.M., Foy, B.D., Sanchez-Vargas, , Beaty, B.J., Blair,
experimental advice Dicer assays S2 cell extracts. B.B.         C.D., Olson, K.E. 2004. RNA interference acts natu- Lebanese CNRSL fellow. work financially sup-                ral antiviral response Oâ€™nyong-nyong virus (Alphavirus;
ported Pasteur Institute CNRS, grant              Togaviridae) infection Anopheles gambiae. Proc. Natl. ARC (#3203) C  NIH grants AI40085                   Acad. Sci. 101: 17240â€“17245.
AI064738 R                                                       Lakatos, L., Csorba, T., Pantaleo, V., Chapman, E.J., Carrington,
                                                                          J.C., Liu, Y.P., Dolja, V.V., Calvino, L.F., Lopez-Moya, J.J.,
                                                                          Burgyan, J. 2006. Small RNA binding common strat-
                                                                          egy suppress RNA silencing viral suppressors.
References
                                                                          EMBO J. 25: 2768â€“2780.
Aravin, , Lagos-Quintana, M., Yalcin, , Zavolan, M.,            Lee, Y.S., Nakahara, K., Pham, J.W., Kim, K.,  , Sonthei-
   Marks, D., Snyder, B., Gaasterland, T., Meyer, J., Tuschl,         mer, E.J., Carthew, R.W. 2004. Distinct roles Dro-
   T. 2003. small RNA profile Drosophila melano-               sophila Dicer-1 Dicer-2 siRNA/miRNA silencing
   gaster development. Dev. Cell 5: 337â€“350.                              pathways. Cell 117: 69â€“81.
Bartel, D.P. 2004. MicroRNAs: Genomics, biogenesis, mecha-            Li, H.W., Li, W.X., Ding, S.W. 2002. Induction suppres-
   nism, function. Cell 116: 281â€“297.                                 sion RNA silencing animal virus. Science 296:
Baulcombe, D. 2004. RNA silencing plants. Nature 431: 356â€“             1319â€“1321.
   363.                                                               Lingel, , Simon, B., Izaurralde, E., Sattler, M. 2005. Baumberger, N. Baulcombe, D.C. 2005. Arabidopsis                      structure flock house virus B2 protein, viral suppres-
   ARGONAUTE1 RNA Slicer selectively recruits                  sor RNA interference, shows novel mode double-
   microRNAs short interfering RNAs. Proc. Natl. Acad.                stranded RNA recognition. EMBO Rep. 6: 1149â€“1155.
   Sci. 102: 11928â€“11933.                                             Liu, J., Carmell, M , Rivas, F.V., Marsden, C.G., Thomson,
Bentwich, , Avniel, , Karov, Y., Aharonov, R., Gilad, S.,             J.M., Song, J.J., Hammond, S.M., Joshua-Tor, L., Hannon,
   Barad, O., Barzilai, , Einat, P., Einav, U., Meiri, E., et al.       G.J. 2004. Argonaute2 catalytic engine mammalian
   2005. Identification hundreds conserved noncon-              RNAi. Science 305: 1437â€“1441.
   served human microRNAs. Nat. Genet. 37: 766â€“770.                   Lu, R., Maduro, M., Li, F., Li, H.W., Broitman-Maduro, G., Li,
Berezikov, E., Guryev, V., van Belt, J., Wienholds, E., Plas-          W.X., Ding, S.W. 2005. Animal virus replication    terk, R.H., Cuppen, E. 2005. Phylogenetic shadowing                RNAi-mediated antiviral silencing Caenorhabditis ele-
   computational identification human microRNA                     gans. Nature 436: 1040â€“1043.
   genes. Cell 120: 21â€“24.                                            Meister, G. Tuschl, T. 2004. Mechanisms gene silencing
Brennan, C  Anderson, K.V. 2004. Drosophila: genet-             double-stranded RNA. Nature 431: 343â€“349.
   ics innate immune recognition response. Annu. Rev.          Merai, , Kerenyi, , Kertesz, S., Magna, M., Lakatos, L.,    Immunol. 22: 457â€“483.                                                  Silhavy, D. 2006. Double-stranded RNA binding Chang, K.Y. Ramos,  2005. double-stranded RNA-                  general plant RNA viral strategy suppress RNA silencing.
   binding motif, versatile macromolecular docking platform.            J. Virol. 80: 5747â€“5756.
   FEBS J. 272: 2109â€“2117.                                            Okamura, K., Ishizuka, , Siomi, H., Siomi, M.C. 2004.
Chao, J , Lee, J.H., Chapados, B.R., Debler, E.W.,                      Distinct roles Argonaute proteins small RNA-directed
   Schneemann, , Williamson, J.R. 2005. Dual modes               RNA cleavage pathways. Genes & Dev. 18: 1655â€“1666.
   RNA-silencing suppression Flock House virus protein B2.         Reed, L.J. Muench, H. 1938. simple method estimating
   Nat. Struct. Mol. Biol. 12: 952â€“957.                                   fifty percent endpoints. J. Hyg. 27: 493â€“497.
Cherry, S. Perrimon, N. 2004. Entry rate-limiting step       Rorth, P. 1998. Gal4 Drosophila female germline. Mech.
   viral infection Drosophila melanogaster model              Dev. 78: 113â€“118.


2994        GENES & DEVELOPMENT
                                                                              Antiviral function Ago2


Ryter, J.M. Schultz, S.C. 1998. Molecular basis double-
   stranded RNAâ€“protein interactions: Structure dsRNA-
   binding domain complexed dsRNA. EMBO J. 17: 7505â€“
   7513.
Saleh, M.C., van Rij, R.P., Hekele, , Gillis, , Foley, E.,
   Oâ€™Farrell, P.H., Andino, R. 2006. endocytic pathway
   mediates cell entry dsRNA induce RNAi silencing.
   Nat. Cell Biol. 8: 793â€“802.
Sanchez-Vargas, , Travanty, E , Keene, K.M., Franz, W.,
   Beaty, B.J., Blair, C.D., Olson, K.E. 2004. RNA interfer-
   ence, arthropod-borne viruses, mosquitoes. Virus Res.
   102: 65â€“74.
Silverstein, M. 1989. history immunology. Funda-
   mental immunology (ed. W.E. Paul), pp. 21â€“38. Raven Press,
    New York.
Sullivan, C. Ganem, D. 2005. virus-encoded inhibitor
    blocks RNA interference mammalian cells. J. Virol.
    79: 7371â€“7379.
Tian, B., Bevilacqua, P.C., Diegelman-Parente, ,     Mathews, M.B. 2004. double-stranded-RNA-binding
    motif: Interference  Nat. Rev. Mol. Cell Biol.
    5: 1013â€“1023.
van Rij, R.P. Andino, R. 2006. silent treatment: RNAi
    defense virus infection mammals. Trends Bio-
    technol. 24: 186â€“193.
Vargason, J.M., Szittya, G., Burgyan, J., Tanaka Hall, T.M.
    2003. Size selective recognition siRNA RNA silenc-
    ing suppressor. Cell 115: 799â€“811.
Voinnet, O. 2005. Induction suppression RNA silencing:
    Insights viral infections. Nat. Rev. Genet. 6: 206â€“220.
Wang, X.H., Aliyari, R., Li, W.X., Li, H.W., Kim, K., Carthew, R.,
    Atkinson, P., Ding, S.W. 2006. RNA interference directs
    innate immunity viruses adult Drosophila. Sci-
    ence 312: 452â€“454.
Xie, 